Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Eledon Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q3 2022
- Shares held
- 6.25M
- −17.1K (−0.3%) vs. Q3 2022
- Total value
- $14.4M
- −$2.92M (−16.9%) vs. Q3 2022
- New holders
- 2
- 7 more added
- Sold out
- 5
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 2,326,710 | $5.40M | 0.23% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,217,882 | $2.78M | 0.19% | −5,618−0.5% | Reduced |
| Vanguard Group Inc | 679,557 | $1.55M | 0.00% | +3140.0% | Added |
| Woodline Partners LP | 516,675 | $1.18M | 0.02% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 443,001 | $1.03M | 0.00% | +355,715+407.5% | Added |
| CM Management, LLC | 234,800 | $535.0K | 0.64% | −10,200−4.2% | Reduced |
| Ikarian Capital, LLC | 221,830 | $514.6K | 0.21% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 129,151 | $299.0K | 0.00% | −314−0.2% | Reduced |
| Eversept Partners, LP | 67,743 | $154.5K | 0.01% | 00.0% | Unchanged |
| Jmac Enterprises LLC | 54,538 | $124.3K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 51,770 | $118.0K | 0.00% | +2,405+4.9% | Added |
| Ingalls & Snyder LLC | 50,849 | $116.0K | 0.01% | −300−0.6% | Reduced |
| State Street Corp | 44,692 | $103.7K | 0.00% | 00.0% | Unchanged |
| SVB Financial Group | 40,613 | $93.1K | 0.25% | +40,613 | New |
| Northern Trust Corp | 30,053 | $68.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 29,673 | $68.0K | 0.00% | −2,200−6.9% | Reduced |
| Two Sigma Advisers, LP | 25,600 | $58.4K | 0.00% | −16,600−39.3% | Reduced |
| Boothbay Fund Management, LLC | 22,050 | $50.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 21,637 | $49.3K | 0.00% | −8,100−27.2% | Reduced |
| Dimensional Fund Advisors LP | 17,954 | $42.0K | 0.00% | +40.0% | Added |
| Mercer Global Advisors Inc | 16,726 | $38.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,992 | $9.10K | 0.00% | +2,978+293.7% | Added |
| Tower Research Capital LLC (TRC) | 1,898 | $4.00K | 0.00% | +1,258+196.6% | Added |
| Rockefeller Capital Management L.P. | 1,666 | $3.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 84 | $192 | 0.00% | +2+2.4% | Added |
| Bank of America Corp | 14 | $32 | 0.00% | +14 | New |
| Morgan Stanley | 1 | $2 | 0.00% | −1,132−99.9% | Reduced |
| IFP Advisors, Inc | 1 | – | – | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −339−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |